About

The Drögemöller Lab uses large-scale genomic and computational analyses to guide the development of novel treatment strategies that offer maximum benefit and minimal harm.

This research is focused specifically on vulnerable and understudied populations (e.g. pediatric and maternal populations) as therapeutic agents are often not designed and tested with these patients in mind.

Principal Investigator

Dr. Britt Drögemöller is an Assistant Professor in the Department of Biochemistry & Medical Genetics at the University of Manitoba. Dr. Drögemöller holds a Canada Research Chair in Pharmacogenomics and Precision Medicine and is appointed as a Research Scientist at The Children’s Hospital Foundation of Manitoba (CHRIM) and an Adjunct Scientist at the CancerCare Manitoba Research Institute.

MSc student

MacKenzie Wilke is a MSc student in the Department of Biochemistry & Medical Genetics at the University of Manitoba. MacKenzie has graduated with her BSc (Hons) in Genetics from the University of Manitoba in 2020. She completed an undergraduate thesis on identifying genes associated with autism spectrum disorder through Hardy-Weinberg disequilibrium and her MSc project will focus on developing a polygenic risk score in order to aid with the prediction and prevention of cisplatin-induced ototoxicity.

MSc student

Samah Ahmed is a MSc student in the Department of Biochemistry & Medical Genetics at the University of Manitoba. Samah has graduated with her B.Pharm from the University of Khartoum in 2010. Her MSc project will focus on identifying genetic variants and genes involved in pathways underlying hearing through GWAS and scRNAseq analyses.

Honours Student

Sarah is an undergrad student at the Univeristy of Manitoba currently pursing a Genetic Honours Co-op degree. Under the supervision of Dr. Drögemöller she is studying genetic variants associated with polycystic ovary syndrome and their role in treatment outcomes of patients.

Mitacs-Globalink UK-Canada PhD exchange student

Danielle Johnson is a PhD student at the University of Liverpool, UK, who has been awarded a Mitacs Globalink internship in the Drögemöller lab. She previously completed her MRes at King’s College London and a BSc in Medical Sciences at the University of Exeter. She previously worked on the STAMPEDE trial at the Medical Research Council, London.

Undergraduate Student

Vaibhav is an undergraduate student at the University of Manitoba pursuing a Major in Microbiology. He will be working under the supervision of Dr. Drögemöller, mining cisplatin-induced gene expression and cytotoxicity data to identify genes of relevance to cisplatin-induced ototoxicity.

Undergraduate Student

Urim Iyasere is an undergraduate student at the Univeristy of Manitoba currently pursing a Genetic Hons Co-op degree. Urim’s summer project will focus on identifying genes that are relevant to cisplatin-induced ototoxicity.